Turner Syndrome Market: Global Industry Analysis and Forecast (2022-2029)

Turner Syndrome Market was valued at US$ 3.6 Bn in 2021. Turner Syndrome Market size is expected to grow at a CAGR of 6.01 % through the forecast period.

Turner Syndrome Market Overview:

Turner syndrome (TS), also known as 45, X, or 45, X0, is a genetic condition in which a female is partially or completely missing an X chromosome. It is caused when X chromosomes or sex chromosomes is missing or partially missing. Women with this syndrome have a range of medical and developmental complications, including shorter than other average females, failure of the ovaries to develop, and complications of heart. Most people with TS have normal intelligence, however, many have problems with spatial visualization that may be needed in order to learn mathematics. Vision and hearing problems also occur more often than average. Turner syndrome has a number of physical and psychological impacts, including short stature, heart defects, neck webbing, delayed or absent puberty, and infertility. Turner Syndrome Market To know about the Research Methodology :- Request Free Sample Report Turner syndrome is a genetic disorder, but it’s usually not inherited, except in rare cases. An inherited genetic condition means that a parent (or both parents) passed down a mutated, or changed, gene. In Turner syndrome, the chromosome change happens randomly before birth. People with Turner syndrome (TS) may have heart and blood vessel problems, some of which can be life-threatening. Up to 50% of people with TS have a problem with the structure of their hearts. The patients with Turner syndrome need lifetime medical care. The report explores the Turner Syndrome Market segments (Type, Drug Type, By Therapy Type, By End User and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2017 to 2021. The report investigates the Turner Syndrome Market drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Turner Syndrome Market contemporary competitive scenario. 2021 is considered as a base year to forecast the market from 2022 to 2029. 2021’s market size is estimated on real numbers and outputs of the key players and major players across the globe. Past five years' trends are considered while forecasting the market through 2029. 2021 is a year of exception and analysis especially with the impact of lockdown by region.

Turner Syndrome Market Dynamics:

The awareness in patient’s parents is increasing which results in a greater number of prenatal testing and infant’s genetic testing which is forecasted to drive the market of turner syndrome. The increasing FDA approvals for the treatment by biotechnology sector and increase in per capita income of people to spend on healthcare facility leads to the growth of the Turner Syndrome Market. Due to the rising population of female and the rising cases of this disease, the market started boosting up during the forecast period. The factors such as awareness in patients, rising number of pre-birth genetic testing, etc. are leading to the market growth. According to the National Library of Medicine about 1 in 2,500 new-born girls are affected with the Turner Syndrome globally. It is one of the causes of female-fatal-miscarriages and stillbirths. These all drives the growth of the global turnover syndrome market. High annual treatment cost is one of the restraints of the growth of the market. Some of the side effects such as vomiting, high blood sugar level, worsening of scoliosis etc. are restraining the market growth during the forecast period. Also, lack of disease awareness leading to slow diagnosis of patients in developed and under-developed countries is expected to affect market growth. The increased risk of diabetes and high blood pressure is also derailing the market growth. In early childhood, girls who have Turner syndrome may have frequent middle ear infections. Recurrent infections can lead to hearing loss in some cases. The heart and blood vessel problems, hearing loss, kidney problems, immune system problems, dental problems such as abnormal tooth development and early tooth loss, vision problems, abnormal curvature of spine, infertility are the restraining factors which leads to the growth of the Turner Syndrome Market during the forecast period. The regular health checks and access to a wide variety of specialists are important to care for the various health problems that can result from Turner syndrome. These include ear infections, high blood pressure, and thyroid problems. There are the two opportunities where turner syndrome can be cured: 1. Human growth hormone: If given in early childhood, hormone injections can often increase adult height by a few inches. 2. Estrogen replacement therapy (ERT): ERT can help start the secondary sexual development that normally begins at puberty (around age 12). This includes breast development and the development of wider hips. Healthcare providers may prescribe a combination of oestrogen and progesterone to girls who haven’t started menstruating by age 15. ERT also provides protection against bone loss. 3. Psychological therapy: Psychological therapy, such as counselling or cognitive behavioural therapy (CBT), may be recommended. Some girls and women with Turner syndrome may develop psychological problems, such as low self-esteem or depression. Doctors sometimes attribute these problems to physical appearance or infertility, but they're more commonly related to difficulties understanding other people's social behaviour and how to respond appropriately. Associated problems often arise at home, in school and in the workplace. COVID-19 Impact on Turner Syndrome Market: Some common medical conditions associated with turner syndrome that are on the list for high-risk of severe illness from COVID-19: 1. People who have serious heart disease: Heart disease found in those with Turner syndrome includes a bicuspid aortic valve and coarctation/narrowing of the aorta. A well-functioning bicuspid aortic valve (BAV) will not likely put a patient at increased risk, although heart disease is an underlying medical condition that can result in severe complications from COVID-19. Please read the special statement regarding medications for those with aortic and vascular disease in the John Ritter Foundation for Aortic Health Statement on COVID-19 below. 2. People with diabetes, particularly if not well-controlled: The incidence of Type 1 and Type 2 diabetes are four times and ten times greater in people with Turner syndrome, respectively. If you have been diagnosed with diabetes, please work with your healthcare provider to make sure the disease is well-managed and monitor. 3. Hypertension / High Blood Pressure: Hypertension is a risk factor in adults with COVID-19, especially when not optimally controlled and when associated with obesity and/or diabetes. 4. Severe Obesity: Obesity is common in those with Turner syndrome. If you are severely obese (body mass index [BMI] of 40 or higher), you are at a greater risk of severe illness from COVID-19. A helpful tool to calculate BMI can be used here. 5. Liver Disease: The occurrence of cirrhosis of the liver is six times greater for people with Turner syndrome. Fatty liver disease is also common with TS. These can predispose a person to COVID-19.

Turner Syndrome Market Segment Analysis:

Based on Type, The classical turner syndrome segment dominated the market with XX% share in 2021. The Classic Tuner Syndrome happens to affect every cell that is present in the female body and on the other hand, only a few cells of the female body are at risk of Mosaic Turner Syndrome. The Classic Turner Syndrome creates some other related complications and it includes dissecting aortic aneurysm, kidney diseases, heart diseases, etc. The Classic Turner Syndrome is more serious than Mosaic Turner Syndrome. In Classic Turner Syndrome all the cells of the body are infected, whereas selected cells are diagnosed in the Mosaic Turner Syndrome. The Classic Turner Syndrome specifically takes place in about 45% of patients diagnosed with the Turner Syndrome. The increasing patients of classic turner syndrome leads to the growth of the Turner Syndrome Market during the forecast period. Turner Syndrome Market

Turner Syndrome Market Regional Insights:

The North America region is expected to witness significant growth at a CAGR of XX% through the forecast period. The increasing adoption of new technologies and huge patient population leads to the growth of Turner Syndrome Market during the forecast period. The other reasons for the growth of the market are the increasing healthcare spending, increasing female population followed by the presence of developed economies and healthcare sector within the region. Europe holds second largest market share in Turner syndrome globally. The major factors such as the rising research and development in pharmaceutical companies, huge patient population, growing biotechnology sector leads to the market growth within the region. Asia-Pacific is expected to grow the market share during the forecast period. Due to the increasing expenditure to develop healthcare infrastructure coupled with rising regularity of genetic disorders in females leads to the growth of the Turner Syndrome Market in this region. The presence of the developing countries like the India and China within the region are accelerating the market growth. The development of health care infrastructure and increase in medical expenditure by governments of these countries will led to the market growth during the forecast period. The objective of the report is to present a comprehensive analysis of the Turner Syndrome Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Turner Syndrome Market dynamic, structure by analyzing the market segments and projecting the Turner Syndrome Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, product portfolio, growth strategies, and regional presence in the Turner Syndrome Market make the report investor’s guide.

Turner Syndrome Market Scope: Inquire before buying

Global Turner Syndrome Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US$ 3.6 Bn.
Forecast Period 2022 to 2029 CAGR: 6.01% Market Size in 2029: US$ 5.74 Bn.
Segments Covered: by Type • Classical Turner Syndrome • Mosaic Turner syndrome
by Drug Type • Norditropin • Oxandrolone • Humatrope • Somatropin • Oxandrin • Genotropin • Nutropin • Zomacton
by Therapy Type • Growth Hormone Therapy • Estrogen and Progesteron • Replacement Therapy • Others
by End-User • Hospitals • Homecare • Specialty Clinics • Surgical Centres • Others

Turner Syndrome Market by Region

• North America • Europe • Asia Pacific • South America • Middle East and Africa

Turner Syndrome Market Key Players

• Novartis AG • Bausch Health • Pfizer Inc. • Johnson & Johnson Services Inc. • Eli Lilly and Company • F. Hoffmann-La Roche Ltd. • Abbott Laboratories • Merck & Co. • Sanofi • GlaxoSmithKline • Astrazeneca • AbbVie Inc. • Allergan • Smiths Group plc • Lupin Pharmaceuticals Inc. • Medtronic • Sandoz International GmbH • Novo Nordisk A/S • American Gene Technologies • Codexis. • BioMarin • Ultragenyx Pharmaceutical Frequently Asked Questions: 1] What segments are covered in the Turner Syndrome Market report? Ans. The segments covered in the Turner Syndrome Market report are based on Type, Drug Type, Therapy Type and End User. 2] Which region is expected to hold the highest share in the Turner Syndrome Market? Ans. North America region is expected to hold the highest share in the Turner Syndrome Market. 3] What is the market size of the Turner Syndrome Market by 2029? Ans. The market size of the Turner Syndrome Market by 2029 is expected to reach US$ 5.74 Bn. 4] What is the forecast period for the Turner Syndrome Market? Ans. The forecast period for the Turner Syndrome Market is 2022-2029. 5] What was the market size of the Turner Syndrome Market in 2021? Ans. The market size of the Turner Syndrome Market in 2021 was valued at US$ 3.6 Bn.
1. Turner Syndrome Market: Research Methodology 2. Turner Syndrome Market: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Turner Syndrome Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Turner Syndrome Market: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12. COVID-19 Impact 4. Turner Syndrome Market Segmentation 4.1. Turner Syndrome Market, By Type (2021-2029) • Classical Turner Syndrome • Mosaic Turner syndrome 4.2. Turner Syndrome Market, By Drug Type (2021-2029) • Norditropin • Oxandrolone • Humatrope • Somatropin • Oxandrin • Genotropin • Nutropin • Zomacton 4.3. Turner Syndrome Market, By Therapy Type (2021-2029) • Growth Hormone Therapy • Estrogen and Progesteron • Replacement Therapy • Others 4.4. Turner Syndrome Market, By End User (2021-2029) • Hospitals • Homecare • Specialty Clinics • Surgical Centres • Others 5. North America Turner Syndrome Market (2021-2029) 5.1. North America Turner Syndrome Market, By Type (2021-2029) • Classical Turner Syndrome • Mosaic Turner syndrome 5.2. North America Turner Syndrome Market, By Drug Type (2021-2029) • Norditropin • Oxandrolone • Humatrope • Somatropin • Oxandrin • Genotropin • Nutropin • Zomacton 5.3. North America Turner Syndrome Market, By Therapy Type (2021-2029) • Growth Hormone Therapy • Estrogen and Progesteron • Replacement Therapy • Others 5.4. North America Turner Syndrome Market, By End User (2021-2029) • Hospitals • Homecare • Specialty Clinics • Surgical Centres • Others 5.5. North America Turner Syndrome Market, by Country (2021-2029) • United States • Canada • Mexico 6. European Turner Syndrome Market (2021-2029) 6.1. European Turner Syndrome Market, By Type (2021-2029) 6.2. European Turner Syndrome Market, By Drug Type (2021-2029) 6.3. European Turner Syndrome Market, By Therapy Type (2021-2029) 6.4. European Turner Syndrome Market, By End User (2021-2029) 6.5. European Turner Syndrome Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Turner Syndrome Market (2021-2029) 7.1. Asia Pacific Turner Syndrome Market, By Type (2021-2029) 7.2. Asia Pacific Turner Syndrome Market, By Drug Type (2021-2029) 7.3. Asia Pacific Turner Syndrome Market, By Therapy Type (2021-2029) 7.4. Asia Pacific Turner Syndrome Market, By End User (2021-2029) 7.5. Asia Pacific Turner Syndrome Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Turner Syndrome Market (2021-2029) 8.1. Middle East and Africa Turner Syndrome Market, By Type (2021-2029) 8.2. Middle East and Africa Turner Syndrome Market, By Drug Type (2021-2029) 8.3. Middle East and Africa Turner Syndrome Market, By Therapy Type (2021-2029) 8.4. Middle East and Africa Turner Syndrome Market, By End User (2021-2029) 8.5. Middle East and Africa Turner Syndrome Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Turner Syndrome Market (2021-2029) 9.1. South America Turner Syndrome Market, By Type (2021-2029) 9.2. South America Turner Syndrome Market, By Drug Type (2021-2029) 9.3. South America Turner Syndrome Market, By Therapy Type (2021-2029) 9.4. South America Turner Syndrome Market, By End User (2021-2029) 9.5. South America Turner Syndrome Market, by Country (2021-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1 Novartis AG 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Bausch Health 10.3. Pfizer Inc. 10.4. Johnson & Johnson Services Inc. 10.5. Eli Lilly and Company 10.6. F. Hoffmann-La Roche Ltd. 10.7. Abbott Laboratories 10.8. Merck & Co. 10.9. Sanofi 10.10. GlaxoSmithKline 10.11. Astrazeneca 10.12. AbbVie Inc. 10.13. Allergan 10.14. Smiths Group plc 10.15. Lupin Pharmaceuticals Inc. 10.16. Medtronic 10.17. Sandoz International GmbH 10.18. Novo Nordisk A/S 10.19. American Gene Technologies 10.20. Codexis. 10.21. BioMarin 10.22. Ultragenyx Pharmaceutical

About This Report

Report ID 74857
Category Healthcare
Published Date July 2022
Updated Date
Contact Us